KT&G (033780) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Jun, 2026Executive summary
Q1 2025 consolidated revenue rose 15.4% year-over-year to KRW 1.4911 trillion, with operating profit up 20.7% to KRW 285.6 billion and adjusted operating profit up 45.1% after excluding one-off early retirement costs, driven by record-high Global CC business performance and improved product mix and pricing.
Net income declined 9.7% to KRW 257.9 billion, while EPS decreased 4.7% to KRW 2,370.
Launched a new co-CEO system to tailor domestic and overseas business strategies, focusing on profitability and localized brand expansion.
Announced plans to diversify into modern products, including nicotine pouches and e-vapor, and initiated projects for future growth through new product launches and expanded partnerships.
Tobacco led with 66.3% of sales, followed by health functional foods (21.1%), real estate (6.7%), and others (5.9%).
Financial highlights
Gross profit margin improved to 50.6% from 49.8% year-over-year; operating profit margin was 19.2%, up from 18.3% in Q1 2024.
EBITDA rose 19.1% to KRW 354.3 billion with a margin of 23.8%.
Cash and cash equivalents at quarter-end: KRW 1,018.7 billion.
Total assets: KRW 14,067.4 billion; total equity: KRW 9,187.6 billion.
Debt-to-equity ratio: 53.1%.
Outlook and guidance
No changes to annual guidance; company remains on track to achieve previously communicated targets.
Will review Q2 performance and market conditions for potential upward revisions.
Focus on accelerating global CC growth, expanding modern product categories, and pursuing inorganic growth opportunities.
Ongoing investment in production capacity, digital transformation, and ESG initiatives.
Expects 2025 to be a year of high uncertainty and risk but is committed to innovation and growth.
Latest events from KT&G
- Record FY24 results with global growth, higher dividends, and aggressive buybacks.033780
Q4 202424 Jun 2026 - Q2 profit jumped on global tobacco gains, but 2024 outlook was cut as HFF and real estate lagged.033780
Q2 202424 Jun 2026 - Record tobacco growth and shareholder returns offset declines in net income and real estate.033780
Q3 202424 Jun 2026 - Record revenue and operating profit growth, but net income fell; dividends and buybacks increased.033780
Q2 202524 Jun 2026 - Record revenue and profit, net income up 73.4%, guidance raised, global expansion planned.033780
Q3 202524 Jun 2026 - Record Q1 revenue and profit growth driven by global tobacco and health foods, with stronger dividends ahead.033780
Q1 202622 Jun 2026 - 2025 saw record revenue, profit, and shareholder returns, led by global CC and real estate growth.033780
Q4 20255 Feb 2026 - Accelerated global growth, record shareholder returns, and new Altria partnership drive expansion.033780
Investor Day 2025 Presentation23 Sep 2025